beta emitter


Also found in: Encyclopedia.

beta emitter

A radioisotope which decays by emitting an electron particle. Beta emitters are labelled as “soft” emitters if the electron is of low energy and has a short penetration distance, or “hard” if it is high-energy and with a great penetrating distance.
References in periodicals archive ?
One day, doctors may even be able to select from a family of beta emitters with different energies--and therapeutic ranges--to tailor the radiation's reach to a particular cancer's size.
European Radiopharmaceuticals Market Diagnostic SPECT Tc-99m Tl-201 Ga-67 I-123 Others PET F-18 Rb-82 Others Therapy Beta emitters I-131 Sm-153 Re-186 Y-90 Lu-177 Others Alpha emitters Brachytherapy Cs-131 I-125 Pd-103 Ir-192 Others
In 2014, the beta emitters segment accounted for the largest share of the radiopharmaceuticals therapeutics market.
In 2014, the beta emitters segment accounted for the largest share of the nuclear medicine/radiopharmaceuticals therapeutics market.
Market is segmented by Beta Emitters (Iodine-131 (I-131), Yttrium-90 (Y-90), Samarium-153 (SM-153), Rhenium-186 (RE-186), Lutetium-177 (LU-177)and Others) Alpha emitters(Radium-223 (RA-223) & Alpharadin, Actinium-225 (AC-225), Lead-212 (PB-212)/Bismuth-212 (BI-212)and Astatine-211 (AT-211)) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103 and Iridium-192), by applications and by geography ( North America, Europe and Asia-Pacific).
Beta emitters contribute the highest to the therapy market, dominated by iodine-131(I-153), which is poised to grow at a decent CAGR of about 5.
This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.
Systemic radiation therapy is bifurcated into two segments: Alpha emitter (Radium (Ra-233) and Beta emitters (Iodine (I-131), Rhenium (Re-186), Samarium (Sm-153), Yttrium-90 (Y-90), Lutetium-177 (LU-177).
While, therapeutic market is segmented as Beta emitters, Alpha emitters and brachytherapy.
Beta emitters are dominated by Iodine-131(I-131), brachytherapy market by Cesium-131( Cs-131), Idoine-125( I-125), Palladium-103(Pd-103) and Iridium-192(Ir-192).
The diagnostic market consists of PET and SPECT technologies, while the therapy market comprises of beta emitters and brachytherapy seeds.